Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR | Market Cap | 39.60B +67.3% |
| Revenue (ttm) | 5.39B +83.9% |
| Net Income | -739.36M |
| EPS | -22.46 |
| Shares Out | 34.63M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 1.00 (0.09%) |
| Ex-Dividend Date | Sep 22, 2025 |
| Volume | 98,525 |
| Open | 1,142.80 |
| Previous Close | 1,143.30 |
| Day's Range | 1,136.20 - 1,221.60 |
| 52-Week Range | 917.20 - 1,740.00 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 22, 2026 |
About Zota Health Care
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India. [Read more]
Financial Performance
In fiscal year 2026, Zota Health Care's revenue was 5.39 billion, an increase of 83.86% compared to the previous year's 2.93 billion. Losses were -739.36 million, 31.1% more than in 2025.
Financial StatementsNews
Zota Health Care reports 83.86% revenue growth in FY26, reaching ₹53,865.75 lakhs
Zota Health Care Limited, a prominent player in the pharmaceutical industry, has reported a robust revenue growth of 83.86% year-on-year for the financial year 2026. The company's consolidated revenue...
Zota Health Care sets Rs 12 crore cap on promoter directors' remuneration
Zota Health Care has announced a new upper cap limit for the cumulative remuneration of its promoter directors, setting it at ₹12 crore annually. This decision is part of the…
Zota Health Care approves Re. 1 per share dividend for FY26
Zota Health Care Limited has announced a final dividend of 10%, equivalent to Re. 1 per equity share of ₹10 each, for the financial year 2025-26. This decision was taken…
Zota Health Care partners with Akshay Kumar as brand ambassador for UGO Generic
Zota Health Care Limited has announced a significant partnership with renowned actor Akshay Kumar, who will serve as the brand ambassador for the company and its brand, UGO Generic. This…
JSW Energy, Coffee Day, Alembic Pharma, Zota Health Care among stocks to watch today in business expansions
A few companies have made significant business moves that are expected to impact their growth trajectory. JSW Energy has received Competition Commission of India (CCI) approval for acquiring 100% shar...
Zota Health Care expands Davaindia network to 1,530 stores, outpacing 805 COCO stores
Zota Health Care Limited has achieved a significant milestone in its Davaindia pharmacy network, reaching 1,530 operational stores as of March 17, 2025. This marks a notable increase from 1,413 stores...
Zota Health Care launches “DavaIndia” B2C online portal and app for seamless medicine delivery
Zota Health Care Limited has introduced the “DavaIndia” B2C online portal and mobile app, revolutionizing the way consumers access essential medicines and healthcare products. Available on both Androi...
Zota Health Care secures product registration licenses for 12 products in Vietnam
Among the twelve products granted licenses, well-known drugs like Telmisartan, Etoricoxib, Levofloxacin, and Rosuvastatin are included. These products have been approved for a validity period of five ...
Zota Health Care expands Davaindia network to 1,294 stores, surpassing 600 COCO operational stores
Zota Health Care Limited has achieved a significant milestone in the expansion of its Davaindia network, with the total number of operational stores reaching 1,294 as of December 4, 2024. This marks a...